Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Recruiting now

Conditions studied: Chronic Pulmonary Aspergillosis

In brief

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Key facts

Study ID

NCT06885905

Run by

Imperial College London

People needed

100

Starts

2024-11-27

Expected to finish

2026-04-23

Last updated by the study team

2025-03-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients >/= 18 years old and able to provide informed consent
• Patients with a diagnosis of chronic pulmonary aspergillosis
• To speak and understand English
• Able to provide informed consent

Where it is running

• Ninewells Hospital & Medical School — Dundee, United Kingdom (enrolling)
• Imperial College London — London, United Kingdom (enrolling)
• Manchester NHS Foundation Trust — Manchester, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.